药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Paricalcitol
Latamoxef
The risk or severity of nephrotoxicity can be increased when Aminophenazone is combined with Latamoxef.
Paricalcitol
Cephalothin Group
The risk or severity of nephrotoxicity can be increased when Aminophenazone is combined with Cephalothin Group.
Paricalcitol
Hydrolyzed Cephalothin
The risk or severity of nephrotoxicity can be increased when Aminophenazone is combined with Hydrolyzed Cephalothin.
Paricalcitol
Cefpodoxime
The risk or severity of nephrotoxicity can be increased when Cefpodoxime is combined with Aminophenazone.
Paricalcitol
Cefoxitin
The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Aminophenazone.
Paricalcitol
Cefonicid
The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Aminophenazone.
Paricalcitol
Cefprozil
The risk or severity of nephrotoxicity can be increased when Cefprozil is combined with Aminophenazone.
Paricalcitol
Cefapirin
The risk or severity of nephrotoxicity can be increased when Cefapirin is combined with Aminophenazone.
Paricalcitol
Colistimethate
The risk or severity of nephrotoxicity can be increased when Colistimethate is combined with Aminophenazone.
Paricalcitol
Cefditoren
The risk or severity of nephrotoxicity can be increased when Cefditoren is combined with Aminophenazone.
Paricalcitol
Ceforanide
The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Aminophenazone.
Paricalcitol
Canrenone
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Canrenone.
Paricalcitol
Canrenoic acid
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Canrenoic acid.
Paricalcitol
Cholestyramine
Cholestyramine can cause a decrease in the absorption of Aminophenazone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Paricalcitol
Colesevelam
Colesevelam can cause a decrease in the absorption of Aminophenazone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Paricalcitol
Omacetaxine mepesuccinate
The risk or severity of bleeding can be increased when Aminophenazone is combined with Omacetaxine mepesuccinate.
Paricalcitol
Enprostil
The therapeutic efficacy of Enprostil can be decreased when used in combination with Aminophenazone.
Paricalcitol
Latanoprostene bunod
The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Aminophenazone.
Paricalcitol
Fluprostenol
The therapeutic efficacy of Fluprostenol can be decreased when used in combination with Aminophenazone.
Paricalcitol
Cloprostenol
The therapeutic efficacy of Cloprostenol can be decreased when used in combination with Aminophenazone.